Open AccessMP16-02 INFLUENCE OF GENETIC POLYMORPHISMS ON THE PHARMACOKINETICS OF SUNITINIB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
Author(s) -
Kazuyuki Numakura,
Nobuhiro Fujiyama,
Makoto Takahashi,
Hiroshi Tsuruta,
Atsushi Maeno,
Mitsuru Saito,
Takamitsu Inoue,
Shintaro Narita,
Mingguo Huang,
Shigeru Satoh,
Takenori Niioka,
Masatomo Miura,
Tomonori Habuchi
Publication year - 2017
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2017.02.508
Subject(s) - sunitinib , medicine , renal cell carcinoma , pharmacokinetics , tyrosine kinase inhibitor , cyp3a5 , oncology , single nucleotide polymorphism , adverse effect , cancer , pharmacology , genotype , gene , genetics , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom